Tanzania is pioneering sickle cell treatment in Africa.
With 11,000+ births affected annually, Tanzania has built one of the largest SCD treatment centers globally, offering exchange blood transfusion (ExBT) & stem cell transplants (HSCT). Since 2021, 1,500 patients screened, 157 identified for advanced therapy, and 22 successfully treated with ExBT. Scaling these treatments continent-wide requires stronger healthcare infrastructure, policy investment & ethical access.
🔑 Reflection: How can African researchers leverage national resources & global partnerships to create sustainable models for advanced SCD therapy without financial & infrastructural limitations?
📌 Read more: BMJ Global Health, ​Xtrafrica
gh.bmj.com
Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps remain in advanced treatments for SCD. To help address this burden, Tanzania has established one of the largest single-centre SCD programmes in the … Continue reading
- 0 Replies
Sorry, there were no replies found.
Log in to reply.